Study the association between myeloperoxidase gene single-nucleotide polymorphism G463A (rs2333227) and coronary artery disease in Iraqi patients
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Wisal Abdulrhman Salem
https://orcid.org/0000-0003-4865-898X
Dawood Salman Ali
https://orcid.org/0000-0003-1381-9480
Hamid Jaddoa Abbas
https://orcid.org/0009-0006-7499-3828
Abstract
Acute coronary syndrome (ACS) is a major cause of morbidity and death globally, which is caused by the multifaceted interaction between oxidative stress and inflammatory processes. The enzyme myeloperoxidase (MPO) is secreted by activated leukocytes and is a determinant of vascular dysfunction and unstable plaque. The genetic variation within the MPO gene, especially G463A (rs2333227), may increase enzyme expression and contribute to disease occurrence. The aim of the study was to examine the relationship between the MPO G463A polymorphism, circulating MPO levels, and the risk of ACS. The case-control study included 129 patients with ACS and 66 apparently healthy controls. Immunoassay techniques were used to measure serum MPO and high-sensitivity troponin I levels, and PCR-based methods were used to assess the MPO G463A polymorphism. The MPO level in serum was significantly higher in ACS patients than in controls (p < 0.001). The ROC analysis revealed an average diagnostic ability for MPO (AUC = 0.686, sensitivity for70.7%). There was a significant association between the MPO G463A polymorphism and ACS susceptibility (p > 0.05). Nonetheless, some genotypes were correlated with changes in MPO levels, and they may contribute to the severity of the diseases. An elevated serum MPO level is strongly correlated with ACS and can serve as a useful biomarker for its detection. Conversely, the MPO G463A polymorphism does not appear to have a significant impact on disease susceptibility but may affect individual differences in the inflammatory response.
Downloads
##plugins.themes.bootstrap3.article.details##
Copyright (c) 2026 Wisal Abdulrhman Salem, Dawood Salman Ali, Hamid Jaddoa Abbas
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
References
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC global burden of cardiovascular diseases writing group. Global burden of cardiovascular diseases and risk factors, 1990-2019: Update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982-3021. https://doi.org/10.1016/j.jacc.2020.11.010
Amini M, Zayeri F, Salehi M. Trend analysis of cardiovascular disease mortality, incidence, and mortality-to-incidence ratio: Results from global burden of disease study 2017. BMC Public Health. 2021;21(1):401. https://doi.org/10.1186/s12889-021-10429-0
Pecoits-Filho R, Stenvinkel P, Marchlewska A, Heimburger O, Bárány P, Hoff CM, Holmes CJ, Suliman M, Lindholm B, Schalling M, Nordfors L. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients. Kidney Int Suppl. 2003;(84):S172-6. https://doi.org/10.1046/j.1523-1755.63.s84.32.x
Quinn M, Zhang RYK, Bello I, Rye KA, Thomas SR. Myeloperoxidase as a promising therapeutic target after myocardial infarction. Antioxidants (Basel). 2024;13(7):788. https://doi.org/10.3390/antiox13070788
Hansildaar R, Vedder D, Baniaamam M, Tausche AK, Gerritsen M, Nurmohamed MT. Cardiovascular risk in inflammatory arthritis: Rheumatoid arthritis and gout. Lancet Rheumatol. 2021;3(1):e58-e70. https://doi.org/10.1016/s2665-9913(20)30221-6
Kubala L, Lu G, Baldus S, Berglund L, Eiserich JP. Plasma levels of myeloperoxidase are not elevated in patients with stable coronary artery disease. Clin Chim Acta. 2008;394(1-2):59-62. https://doi.org/10.1016/j.cca.2008.04.001
Adam LN, Al-Habib OAM, Oraha AY, Shekha MS. Genetic and clinical study of myeloperoxidase's association with coronary artery disease. Egypt Heart J. 2024;76(1):27. https://doi.org/10.1186/s43044-024-00457-7
Marsche G, Stadler JT, Kargl J, Holzer M. Understanding Myeloperoxidase-induced damage to HDL structure and function in the vessel wall: Implications for HDL-Based therapies. Antioxidants (Basel). 2022;11(3):556. https://doi.org/10.3390/antiox11030556
Arnhold J. The dual role of myeloperoxidase in immune response. Int J Mol Sci. 2020;21(21):8057. https://doi.org/10.3390/ijms21218057
Aratani Y. Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018;640:47-52. https://doi.org/10.3892/br.2022.1536
Frangie C, Daher J. Role of myeloperoxidase in inflammation and atherosclerosis (Review). Biomed Rep. 2022;16(6):53. https://doi.org/10.3892/br.2022.1536
Alqazzaz M, Mohammed I H, Moayed H. Evaluation of myeloperoxidase (MPO) genetic polymorphism in Iraqi patients with acute myocardial infarction (AMI). Egypt J Chem. 2022;65(6):171-180. https://doi.org/10.21608/ejchem.2021.99019.4604
Tromp J, Paniagua SMA, Lau ES, Allen NB, Blaha MJ, Gansevoort RT, Hillege HL, Lee DE, Levy D, Vasan RS, van der Harst P, van Gilst WH, Larson MG, Shah SJ, de Boer RA, Lam CSP, Ho JE. Age-dependent associations of risk factors with heart failure: Pooled population-based cohort study. BMJ. 2021;372:n461. https://doi.org/10.1136/bmj.n461
Wang P, Yao J, Xie Y, Luo M. Gender-specific predictive markers of poor prognosis for patients with acute myocardial infarction during a 6-month follow-up. J Cardiovasc Transl Res. 2020 Feb;13(1):27-38. https://doi.org/10.1136/bmj.n461
Hammodi MA, Ajlan S, Hazza MA. Prevalence of metabolic syndrome among patients with coronary artery disease in Basrah, Iraq. Anaesth. pain intensive care. 2024;28(1):353−357. https://doi.org/10.35975/apic.v28i2.2419
Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS. American heart association council on epidemiology and prevention statistics committee and stroke statistics subcommittee. Heart disease and stroke statistics-2019 update: A report from the American heart association. Circulation. 2019;139(10):e56-e528. https://doi.org/10.1161/cir.0000000000000659
Rodgers JL, Jones J, Bolleddu SI, Vanthenapalli S, Rodgers LE, Shah K, Karia K, Panguluri SK. Cardiovascular risks associated with gender and aging. J Cardiovasc Dev Dis. 2019;6(2):19. https://doi.org/10.3390/jcdd6020019
Sharhan R, Abdulbari A, Muhammed A. The association between lipid profile and severity of coronary artery disease as assessed by angiography. The medical journal of Basrah University. 2017;35(1):48-55. https://doi.org/10.33762/mjbu.2017.126919
Lan Q, Zheng L, Zhou X, Wu H, Buys N, Liu Z, Sun J, Fan H. The value of blood urea nitrogen in the prediction of risks of cardiovascular disease in an older population. Front Cardiovasc Med. 2021;8:614117. https://doi.org/10.3389/fcvm.2021.614117
Gu X, Li Y, Chen S, Yang X, Liu F, Li Y, Li J, Cao J, Liu X, Chen J, Shen C, Yu L, Huang J, Lam TH, Fang X, He Y, Zhang X, Lu X, Wu S, Gu D. Association of lipids with ischemic and hemorrhagic stroke: A prospective cohort study among 267 500 Chinese. Stroke. 2019 Dec;50(12):3376-3384. https://doi.org/10.1161/strokeaha.119.026402
Santos-Gallego CG, Badimon JJ, Rosenson RS. Beginning to understand high-density lipoproteins. Endocrinol Metab Clin North Am. 2014;43(4):913-47. https://doi.org/10.1016/j.ecl.2014.08.001
Lind L, Sundström J, Ärnlöv J, Lampa E. Impact of aging on the strength of cardiovascular risk factors: A longitudinal study over 40 years. J Am Heart Assoc. 2018 Jan 6;7(1): e007061. https://doi.org/10.1161/jaha.117.007061
Sattar N, Rawshani A, Franzén S, Rawshani A, Svensson AM, Rosengren A, McGuire DK, Eliasson B, Gudbjörnsdottir S. Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks. Circulation. 2019;139(19):2228-2237. https://doi.org/10.1161/circulationaha.118.037885
ZA Almnaseer, AN Mohammed, ZM Mohammed, HJ Abbas. Biomarker-based insights into the impact of type 2 diabetes on cardiovascular health. J Bras Patol Med Lab. 2023;60(1):61-64. https://faculty.uobasrah.edu.iq/uploads/publications/1745913798.pdf
Lan NSR, Bell DA, McCaul KA, Vasikaran SD, Yeap BB, Norman PE, Almeida OP, Golledge J, Hankey GJ, Flicker L. High-sensitivity cardiac troponin I improves cardiovascular risk prediction in older men: HIMS (The Health in Men Study). J Am Heart Assoc. 2019;8(5): e011818. https://doi.org/10.1161/jaha.118.011818
Khine HW, Teiber JF, Haley RW, Khera A, Ayers CR, Rohatgi A. Association of the serum myeloperoxidase/high-density lipoprotein particle ratio and incident cardiovascular events in a multi-ethnic population: Observations from the Dallas Heart Study. Atherosclerosis. 2017;263:156-162. https://doi.org/10.1016/j.atherosclerosis.2017.06.007
Mohammed AM, Almnaseer ZA, Abbas HJ, Adnan MA, Mohammed ZM. Association of Lipid profiles and oxidative stress markers with myocardial infarction in individuals with and without diabetes: A comparative analysis. Research Journal of Biotechnology. 2024;19(10):46-51. https://doi.org/10. 25303/ 1910rjbt046051
Özkan E, Celik Y, Yucel-Lindberg T, Peker Y. Current smoking determines the levels of circulating MPO and MMP-9 in adults with coronary artery disease and obstructive sleep apnea. J Clin Med. 2023;12(12):4053. https://doi.org/10.3390/jcm12124053
Kolodziej AR, Abo-Aly M, Elsawalhy E, Campbell C, Ziada KM, Abdel-Latif A. Prognostic role of elevated myeloperoxidase in patients with acute coronary syndrome: A systemic review and meta-analysis. Mediators Inflamm. 2019;2019:2872607. https://doi.org/10.1155/2019/2872607
Li YY, Wang H, Qian J, Kim HJ, Wu JJ, Wang LS, Zhou CW, Yang ZJ, Lu XZ. PRISMA-combined Myeloperoxidase -463G/A gene polymorphism and coronary artery disease: A meta-analysis of 4744 subjects. Medicine (Baltimore). 2017;96(12):e6461. https://doi.org/10.3390/healthcare11070966
Mäkelä R, Karhunen PJ, Kunnas TA, Ilveskoski E, Kajander OA, Mikkelsson J, Perola M, Penttilä A, Lehtimäki T. Myeloperoxidase gene variation as a determinant of atherosclerosis progression in the abdominal and thoracic aorta: an autopsy study. Lab Invest. 2003;83(7):919-25. https://doi.org/10.1097/01.lab.0000077981.49367.46
Hoy A, Trégouët D, Leininger-Muller B, Poirier O, Maurice M, Sass C, Siest G, Tiret L, Visvikis S. Serum myeloperoxidase concentration in a healthy population: biological variations, familial resemblance and new genetic polymorphisms. Eur J Hum Genet. 2001;9(10):780-6. https://doi.org/10.1038/sj.ejhg.5200702
Uppal N, Uppal V, Uppal P. Progression of coronary artery disease (CAD) from stable angina (SA) towards myocardial infarction (MI): Role of oxidative stress. J Clin Diagn Res. 2014;8(2):40-3. https://doi.org/10.7860/jcdr/2014/7966.4002